Tolterodine
- Generic Name
- Tolterodine
- Brand Names
- Detrol, Detrusitol
- Drug Type
- Small Molecule
- Chemical Formula
- C22H31NO
- CAS Number
- 124937-51-5
- Unique Ingredient Identifier
- WHE7A56U7K
- Background
Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.
- Indication
For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
- Associated Conditions
- Urinary Urge Incontinence
- Associated Therapies
- -
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
- Conditions
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2007-02-21
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 100
- Registration Number
- NCT00313924
- Locations
- 🇮🇱
Rambam Healthcare Center, Haifa, Israel
MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.
- Conditions
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 118
- Registration Number
- NCT00174798
- Locations
- 🇺🇸
Hudson Valley Urology Center, Kingston, New York, United States
🇺🇸Hudson Valley Urology, Poughkeepsie, New York, United States
🇺🇸Rockhill Medical Plaza, Kansas City, Missouri, United States
Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
- Conditions
- Interventions
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2013-06-17
- Lead Sponsor
- Carelon Research
- Target Recruit Count
- 307
- Registration Number
- NCT00090584
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸Oakwood Hospital and Medical Center, Royal Oak, Michigan, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.